☰ 🔍
🖊️Ask a Question
Electrical Engineering

In the treatment of parkinsonism, bromocriptine differs from levodopa in the following respects except: A. It does not need conversion to an active metabolite B. It has a longer duration of action C. It activates dopamine D2 receptors, with little/antagonistic action on D1 receptors D. It does not produce behavioral/psychiatric side effect

by 0 views
In the treatment of parkinsonism, bromocriptine differs
from levodopa in the following respects except:
A. It does not need conversion to an active
metabolite
B. It has a longer duration of action
C. It activates dopamine D2 receptors, with
little/antagonistic action on D1 receptors
D. It does not produce behavioral/psychiatric
side effect
0 like 0 dislike

1 Answer

by
D. It does not produce behavioral/psychiatric
side effects
0 like 0 dislike

Related questions

by trupti chikram asked Jul 23, 2021 1 view
Ropinirole differs from bromocriptine in the following respect: A. It does not directly activate dopamine D2 receptors B. It produces milder gastrointestinal side effects C. In early cases of parkinsonism, it is less likely to need levodopa supplementation D. Both 'B' and 'C' are correct

Ropinirole differs from bromocriptine in the following respect: A. It does not directly activate dopamine D2 receptors B. It produces milder gastrointestinal side effects C. In early cases of parkinsonism, it is less likely to need levodopa supplementation D. Both 'B' and 'C' are correct
Answer : D. Both 'B' and 'C' are correct...

View solution
0 like 0 dislike
1 answer
by trupti chikram asked Jul 23, 2021 0 views
Though bromocriptine acts directly on dopamine receptors, it is used in parkinsonism only as a supplement to levodopa because: A. It has low efficacy B. It produces marked dyskinesias C. Used alone, its effective doses produce intolerable side effects D. Its therapeutic effect takes long time to develop

Though bromocriptine acts directly on dopamine receptors, it is used in parkinsonism only as a supplement to levodopa because: A. It has low efficacy B. It produces marked dyskinesias C. ... its effective doses produce intolerable side effects D. Its therapeutic effect takes long time to develop
Answer : C. Used alone, its effective doses produce intolerable side effect...

View solution
0 like 0 dislike
1 answer
by trupti chikram asked Jul 23, 2021 0 views
Enalapril differs from captopril in that: A. It blocks angiotensin II receptors B. It does not produce cough as a side effect C. It is less liable to cause abrupt first dose hypotension D. It has a shorter duration of action

Enalapril differs from captopril in that: A. It blocks angiotensin II receptors B. It does not produce cough as a side effect C. It is less liable to cause abrupt first dose hypotension D. It has a shorter duration of action
Answer : C. It is less liable to cause abrupt first dose hypotension...

View solution
0 like 0 dislike
1 answer
by trupti chikram asked Jul 22, 2021 0 views
Carbimazole differs from propylthiouracil in that: A. It is dose to dose less potent B. It has a shorter plasma half life C. It does not produce an active metabolite D. It does not inhibit peripheral conversion of thyroxine to triiodothyronine

Carbimazole differs from propylthiouracil in that: A. It is dose to dose less potent B. It has a shorter plasma half life C. It does not produce an active metabolite D. It does not inhibit peripheral conversion of thyroxine to triiodothyronine
Answer : D. It does not inhibit peripheral conversion of thyroxine to triiodothyronine...

View solution
0 like 0 dislike
1 answer
by trupti chikram asked Jul 23, 2021 0 views
The following is true about entacapone except: A. It acts by inhibiting degradation of dopamine in the brain B. If prolongs the therapeutic effect of levodopacarbidopa in parkinsonism C. It can accentuate levodopa induced dyskinesias D. It can cause diarrhoea as a side effec

The following is true about entacapone except: A. It acts by inhibiting degradation of dopamine in the brain B. If prolongs the therapeutic effect of levodopacarbidopa in parkinsonism C. It can accentuate levodopa induced dyskinesias D. It can cause diarrhoea as a side effec
Answer : A. It acts by inhibiting degradation of dopamine in the brain...

View solution
0 like 0 dislike
1 answer

50.5k questions

47.1k answers

240 comments

7.0k users

© 2025 Question Answer